Skip to main content
. 2017 Dec 27;9:14–15. doi: 10.1016/j.lrr.2017.12.002

Fig. 1.

Fig. 1

: Clinical outcome and platelet (PLT) count in a ITP patient associated with 3% of a JAK2V617F allele burden (AB) followed ET with 27% of AB after 13 years.